Food Processing Sector-“priority sector” in India’s Make in India Programme
India is one of the quickest growing economies in the world. India has climbed 30 ranks in the World Bank’s ease of doing Business rankings 2017 and was ranked number 1 in the world in 2016 in greenfield investment. The government of India is undertaking a range of transformational initiatives as a result of which India is also rapidly progressing on the Global Innovation Index, Global Logistics Index and Global Competitiveness Index. World Food India (WFI) was a gateway to the Indian food economy and an opportunity to showcase, connect, and collaborate.
“World Food India 2017”
A global event to facilitate partnerships between Indian and international businesses and investors held in India from 3rd Nov 2017 to 5th Nov 2017. World Food India 2017 was organized by the Ministry of Food Processing Industries, Government of India and was inaugurated by Honourable Prime Minister Narendra Modi at Vigyan Bhavan in New Delhi on 3rd Nov 2017. World Food India 2017 hosted the largest gathering of investors, manufacturers, producers, food processors, policy makers, and organizations from the global food ecosystem to provides opportunities for both investment and trade in the food processing sector for leading Indian and International companies.
Food Processing Sector is the”priority sector” in India’s Make in India Programme. India is now the most preferred investment destination in the Food processing Sector because 100% Foreign Direct Investment (FDI) is now permitted, for trading, including via e-commerce, of food products manufactured in India. As an incentive from the Union and state governments, it has become very easy to obtain loans for food and agro-based processing units, and cold chains at low Interest Rates.
Nivesh Bandhu or investor’s friend is a one of its kind portal launched by Government of India to bring together information on Central and State Government policies and incentives provided for the food processing sector. It is also a platform for business networking, for farmers, processors, traders, and logistics operators.
India has a long tradition of medicine and has many things to offer to the world. Dietary supplements & pharmaceutical compounds can be patented if the formulation is novel in the market.
Most of us know that good nutrition and a balanced diet are important for good health. In the current scenario, the demand for dietary supplements for adults as well as children is constantly increasing. To meet the demands many new products are being researched and introduced to the consumer market. Various dietary supplements are sold in different combinations to provide specific effect in the human body. For example, a combination of dietary supplements includes ingredients to provide strength to the body, desired weight and some provide stress relief. So for an industry overflowing with new products, new formulations and new ideas, protecting the intellectual property is essential to business success.
Currently, over-the-counter (OTC) and prescription drugs play a vital role in health care system.
While both are regulated by Food and Drug Administration, over-the-counter (OTC) drug products are available to consumers without a prescription. There are more than 80 therapeutic categories of over-the-counter (OTC) drugs, ranging from acne drug products to weight control products, and over 100,000 over-the-counter (OTC) drugs are currently being sold in India.
Thus, over-the-counter (OTCs) are critical to country’s health care system because they provide easy access to certain drugs that can be used safely without the help of a healthcare practitioner.
Why intake of dietary supplements & pharmaceutical compounds necessary for human body?
The medical and health management of certain anemias can be handled rather well by increasing the daily intake of iron in diets. In other cases, heavy physical exercise may require the intake of considerable quantities of minerals apart from those generally obtained through what otherwise would be considered a balanced diet.
Recent Patents of Dietary Supplements and Pharmaceutical Compounds:-
Date of Publication- 21st Sept 2017
Title- NATURAL COMPOSITIONS CONTAINING EGGSHELL CALCIUM, ORGANIC HONEY AND LEMON
The present invention discloses compositions and edible orally delivered products, such as candies, beverages, nutritional bars and dietary supplements that increase bone growth and treat age-related bone loss in humans. The major component of the invention is biological calcium which is derived from natural eggshell powder. The compositions also include organic honey and lemon.
US 20170280749 A1
Date of Publication- 5th Oct 2017
Title- ANTIHISTAMINES COMBINED WITH DIETARY SUPPLEMENTS FOR IMPROVED HEALTH
The present invention provides combinations comprising a sedating antihistamine and selected indole-based natural products such as L-tryptophan, 5-hydroxytryptophan and melatonin, along with pharmaceutically acceptable calcium and magnesium salts and selected B vitamins. These combinations are useful in providing a medicament for improving sleep in mammals, especially humans.
US 20170151274 A1
Date of Publication- 1st June 2017
Title- COMPOSITIONS AND METHODS FOR ENHANCING IMMUNITY
The present disclosure relates generally to immunostimulatory compositions, and more specifically to immunostimulatory compositions containing a β-glucan preparation, a ginseng extract, and a mushroom extract.
US 20170202806 A1
Date of Publication- 20th July 2017
Title- COMBINATION DRUG THERAPIES FOR CANCER AND METHODS OF MAKING AND USING THEM
In alternative embodiments, provided are therapeutic combinations, pharmaceutical compositions, formulations, kits and devices for treating, preventing or ameliorating a tumor or a cancer, and methods and uses for treating, preventing or ameliorating a tumor or a cancer. In alternative embodiments, provided are therapeutic combinations, pharmaceutical compositions, formulations, kits and devices comprising: a beta adrenergic receptor antagonist (a “beta blocker”) such as propranolol; a non-steroidal anti-inflammatory drug (a NSAID) such as etodolac; and, a sorafenib or NEXAVAR™ or equivalent thereof. In alternative embodiments, the therapeutic combinations further comprise an anti-cancer or anti-tumor antibody, a cytokine, and/or an additional chemotherapeutic agent. In alternative embodiments, the methods, uses, therapeutic combinations, pharmaceutical compositions, formulations, kits and devices are used for treating, preventing or ameliorating a hepatocarcinoma or hepatocellular carcinoma (HCC), an adenocarcinoma, a metastatic adenocarcinoma of the liver, or an advanced hepatocellular carcinoma.
US 20170056339 A1
Date of Publication- 2nd March 2017
Title- FORMULATION OF FAT-SOLUBLE VITAMIN
The invention relates to a composition comprising A) microcapsules comprising at least one fat-soluble active substance selected from a vitamin K compound or a provitamin or a prodrug of a vitamin K compound embedded in a matrix comprising a hydrocolloid and optionally one or more other matrix components, and B) at least one dietary mineral; as well as uses and products comprising such compositions.
US 20170068777 A1
Date of Publication- 9th March 2017
Title- METHODS OF IDENTIFYING AND FORMULATING FOOD COMPOUNDS THAT MODULATE PHENOTYPE-RELATED TARGETS
This invention relates generally to (but is not limited to) identifying food compounds that have an impact on a phenotype of interest in a subject, and more particularly to identifying a phenotype-related target, identifying a stimulus (e.g., a pharmaceutical agent) that modulates that target, and identifying food compounds exhibiting similarity to the agent (e.g., having a chemical structure that is similar to the agent’s structure). The similarity can be determined, for example, by a computer-interfaced comparison between a drug database and a food database.
US 20160213629 A1
Date of Publication- 28th July 2016
Title- METHOD FOR ENHANCING ENERGY PRODUCTION AND METABOLISM IN CELLS
The present invention relates to use of a composition comprising D-glyceric acid (DGA), DL-glyceric acid, L-glyceric acid, or hydroxypyruvatic acid and/or their salts or esters. Further, the invention relates to the use of said composition for enhancing direct and indirect mitochondrial metabolism, e.g. the ATP producing electron transport system (ETS), citric acid cycle or tricarboxylic acid cycle, (TCA), and beta oxidation, and also enhancing the shuttling of reducing equivalents from mitochondrial matrix into the cytosol and protein synthesis in the endoplasmic reticulum. Directly related to the above the use of DGA relates also to reducing the formation of reactive oxygen species (ROS). Alleviating, preventing and even healing effects towards extremely wide range of non-communicable diseases materializes.
United States Patent 9704096 B2
Date of Publication- 11th July 2017
Title- METHOD AND SYSTEM FOR MAKING CUSTOMIZED FORMULATIONS FOR INDIVIDUALS
The one or more embodiments disclosed herein provide a method for automatically assembling multiple components into a single edible custom composition, in which each compound is individually customized to proportions formulated from a profile of an individual or group. The single custom mixture can contain a plurality of compounds including foods or flavors, nutritional additives, herbals, biologics, or pharmacologically active substances. Using the method and a related algorithm, the formulation of a custom mixture is suggested.
Therefore, when protecting intellectual property by way of filing patents which is a part of a corporate strategy, the patent law can protect valuable research such as product formulations. The protected and patenting pending technologies will provide competitive advantage over any third party in the form of product formulation patents. Discuss your patenting legal issues with our team of experienced patent attorneys and patent agents.